US Patent 7282202 Interleukin-6 suppressive agent
Patent 7282202 was granted and assigned to Morinaga on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Hiroyuki Wakabayashi0
Kimiyasu Shiraki0
Koji Yamauchi0
Kouichirou Shin0
Masahiko Kurokawa0
Yoshitaka Tamura0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+348 characters)
Article
Patent abstract
An interleukin-6 suppressive agent comprising lactoperoxidase as an active ingredient is used as a pharmaceutical preparation or the like for prevention and/or therapy of a disease caused by production of interleukin-6, such as thrombocytosis, myeloma, Castleman syndrome, rheumatoid arthritis, or influenza-virus infectious disease.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07282202 Interleukin-6 suppressive agent US Patent 7282202 Interleukin-6 suppressive agent
Infobox
Patent Number
07282202
Patent Number
7282202
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07282202 Interleukin-6 suppressive agent
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07282202
Date of patent
October 16, 2007
Patent application number
10518018
Date Filed
November 25, 2003
Patent primary examiner
Find more entities like US Patent 7282202 Interleukin-6 suppressive agent
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
